Malignant arrhythmias: Amiodarone may be drug of choice

January 1994
Geriatrics;Jan94, Vol. 49 Issue 1, p57
Academic Journal
Reports on new data which suggest that high-dose IV amiodarone HCl (Cordarone) may be the drug of choice for suppressing life-threatening ventricular arrhythmias in patients with severe underlying heart disease. Side-effects of drugs currently used; Study setup; Medical implications.


Related Articles

  • A new option for ventricular arrythmias. Cerrato, Paul L. // RN;Feb96, Vol. 59 Issue 2, p79 

    Reports on the availability of an intravenous formulation of amiodarone for the treatment and prevention of ventricular fibrillation. Types of patients suitable for the drug; Dosages; Contraindications.

  • Amiodarone.  // Reactions Weekly;9/8/2012, Issue 1418, p9 

    The article describes the case of a 59-year-old woman who developed a prolonged QTc interval, torsade de pointes and ventricular fibrillation while being treated with amiodarone for sustained monomorphic ventricular tachycardia.

  • Intravenous amiodarone in ventricular fibrillation. Chapman, J.R.; Boyd, M.J. // British Medical Journal (Clinical Research Edition);3/21/1981, Vol. 282 Issue 6268, p951 

    Investigates the intravenous amiodarone in ventricular fibrillation in Great Britain. Availability of amiodarone; Efficacy of amiodarone on arrhythmias; Protective effects of amiodarone on ventricular fibrillation, ventricular ectopic beats and ventricular tachcardia.

  • Amiodarone as Compared with Lidocaine for Shock-Resistant Ventricular Fibrillation. Dorian, Paul; Cass, Dan; Schwartz, Brian; Cooper, Richard; Gelaznikas, Robert; Barr, Aiala // New England Journal of Medicine;3/21/2002, Vol. 346 Issue 12, p884 

    Background: Lidocaine has been the initial antiarrhythmic drug treatment recommended for patients with ventricular fibrillation that is resistant to conversion by defibrillator shocks. We performed a randomized trial comparing intravenous lidocaine with intravenous amiodarone as an adjunct to...

  • Propranolol efficiency in prevention of sustained ventricular tachycardia in patients with implanted cardioverter-defibrillator: a case series. Puljević, Mislav; Velagić, Vedran; Puljević, Davor; Miličić, Davor // Croatian Medical Journal;Feb2014, Vol. 55 Issue 1, p75 

    A letter to the editor is presented regarding the implanted cardioverter-defibrillator (ICD) patients and prevention of recidivate ventricular arrhythmia in patients.

  • Effectiveness of VF induction with DC fibber versus conventional induction methods in patients on chronic amiodarone therapy. Rubenstein, Jason; Gupta, Manish; Kim, Michael // Journal of Interventional Cardiac Electrophysiology;Nov2013, Vol. 38 Issue 2, p137 

    Background: Amiodarone therapy, especially chronic, can result in difficult ventricular fibrillation (VF) inductions during implantable cardioverter defibrillator (ICD) testing. The efficacy of various VF induction methods on patients treated with amiodarone has not been well described. This...

  • Amiodarone Induced Epididymitis: A Case Report. Cicek, Tufan; Demir, Canan Cicek; Coban, Gokcen; Coner, Ali // Iranian Red Crescent Medical Journal;Jan2014, Vol. 16 Issue 1, p1 

    Introduction: Amiodarone is an effective drug for life-threatening arrhythmias like recurrent ventricular fibrillation and atrial fibrillation. Amiodarone creates rarely genitourinary side effects are seen. These are epididymitis, testicular dysfunction and impotance. Amiodarone aggregates and...

  • Efficacy of amiodarone on refractory ventricular fibrillation resistant to lidocaine and cardioversion during weaning from cardiopulmonary bypass in aortic valve replacement for severe aortic stenosis with left ventricular hypertrophy. Morita, Yoshihisa; Mizuno, Ju; Yoshimura, Tatsuya; Morita, Shigeho // Journal of Anesthesia;2010, Vol. 24 Issue 5, p761 

    Intravenous injection of amiodarone, a class III anti-arrhythmic is widely used for persistent refractory arrhythmias. We present a case report suggesting the efficacy of amiodarone in refractory ventricular fibrillation (Vf) during weaning from cardiopulmonary bypass (CPB). A 66-year-old woman...

  • Amiodarone/quinidine.  // Reactions Weekly;8/4/2007, Issue 1163, p5 

    The article discusses the case of a female older patient with hereditary hemolytic anemia who developed long QT syndrome followed by torsade de pointes and ventricular fibrillations during treatment with amiodarone and quinidine. The patient's symptoms recurred and her conditioned worsened after...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics